Vaccination milestone: the UK approves vaccine by Johnson and Johnson

The Medication and Healthcare Products Regulatory Agency appreciates efforts by Johnson and Johnson in approving their vaccine production.

The Medicines and Healthcare products Regulatory Agency (MHRA) announced the approval of the Johnson & Johnson single-dose Covid-19 vaccine on Friday. It received sanction from the United Kingdom.
It is the fourth Covid-19 vaccine to be authorized by the UK's independent regulator and the first to be approved for protection against the Covid-19 with a single dose.
"We have undertaken a thorough review of the conditional marketing authorization application submitted by Janssen (part of Johnson & Johnson), including the information on quality, safety and effectiveness. I am pleased to confirm today that this authorization has been granted," MHRA Chief Executive June Raine said in a statement.
"This is encouraging news for the public and the healthcare sector. We now have four safe and effective vaccines approved to help protect us from Covid-19," Raine added.
"This is encouraging news for the public and the healthcare sector. We now have four safe and effective vaccines approved to help protect us from Covid-19," Raine added.
representative image
Image: representative image
The MHRA also obtained independent scientific advice from the Commission on Human Medicines (CHM) and its Covid-19 Expert Working Group. The MHRA approval authorizes the use of the vaccine in people aged 18 and over.
The decision on whether to use the vaccine in pregnant or breast-feeding women should be made in consultation with a healthcare professional after considering the benefits and risks.



Be the first to start a discussion here. Sign-in to write a comment now!